In 2023, Kwang Dong Pharmaceutical posted a sales revenue of around 1.5 trillion South Korean won. This represents an increase from the previous years, as well as the highest revenue recorded. Sales revenue first exceeded one trillion won in 2016. The company is mainly involved with the manufacturing and distribution of pharmaceuticals. Kwang Dong Pharmaceuticals is considered one of
Sales revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in South Korea
Overview
7
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Premium Statistic Pharmaceutical medications sales South Korea 2019-2022
- Premium Statistic Pharmaceutical medications taken in South Korea 2019-2022
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
Production and distribution
6
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
International trade
6
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2022
- Premium Statistic Pharmaceutical import value in South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2022
Key players
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2023, by revenue
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2013-2023
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
Pharmaceutical drug consumption
5
- Premium Statistic Pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Value of pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Major pharmaceutical level 1 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 2 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 3 drugs consumed South Korea 2022
Further related statistics
20
- Total liabilities of the Ipsen group 2014-2019
- Total equity of the Ipsen group 2014-2019
- Research and development expenditure of the Ipsen group 2014-2019
- Operating profit of the Ipsen group 2014-2019
- Italy: R&D investments of leading pharmaceutical companies 2007-2017
- Italy: perception of pharmaceutical companies 2018, by brand
- Pharmaceutical market size Japan 2008-2015
- Consolidated net profit of the Ipsen group 2014-2019
- Pharmaceutical industry: Italian companies' revenues 2007-2017
- Total assets of the Ipsen group 2014-2019
- Italy: international turnover of leading pharmaceutical companies 2007-2017
- Medication sales of the Ipsen Group 2019
- Sales expenses of selected Chinese pharma companies 2021-2022
- Global revenue of the Ipsen group 2019, by geographical area
- Commercial expenses of the Ipsen group 2014-2019
- Global revenue of the Ipsen group 2014-2019
- R&D expense revenue share of selected Chinese pharma companies 2021-2022
- Global revenue in specialty medicine of the Ipsen group 2014-2019
- Global revenue in general medicine of the Ipsen group 2014-2019
- Top known pharma companies by Americans 2017
Further Content: You might find this interesting as well
Statistics
- Total liabilities of the Ipsen group 2014-2019
- Total equity of the Ipsen group 2014-2019
- Research and development expenditure of the Ipsen group 2014-2019
- Operating profit of the Ipsen group 2014-2019
- Italy: R&D investments of leading pharmaceutical companies 2007-2017
- Italy: perception of pharmaceutical companies 2018, by brand
- Pharmaceutical market size Japan 2008-2015
- Consolidated net profit of the Ipsen group 2014-2019
- Pharmaceutical industry: Italian companies' revenues 2007-2017
- Total assets of the Ipsen group 2014-2019
- Italy: international turnover of leading pharmaceutical companies 2007-2017
- Medication sales of the Ipsen Group 2019
- Sales expenses of selected Chinese pharma companies 2021-2022
- Global revenue of the Ipsen group 2019, by geographical area
- Commercial expenses of the Ipsen group 2014-2019
- Global revenue of the Ipsen group 2014-2019
- R&D expense revenue share of selected Chinese pharma companies 2021-2022
- Global revenue in specialty medicine of the Ipsen group 2014-2019
- Global revenue in general medicine of the Ipsen group 2014-2019
- Top known pharma companies by Americans 2017
DART. (March 22, 2024). Sales revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/statistics/1269691/kwang-dong-pharmaceutical-sales-revenue/
DART. "Sales revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in billion South Korean won)." Chart. March 22, 2024. Statista. Accessed May 11, 2024. https://www.statista.com/statistics/1269691/kwang-dong-pharmaceutical-sales-revenue/
DART. (2024). Sales revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/statistics/1269691/kwang-dong-pharmaceutical-sales-revenue/
DART. "Sales Revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 22 Mar 2024, https://www.statista.com/statistics/1269691/kwang-dong-pharmaceutical-sales-revenue/
DART, Sales revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/1269691/kwang-dong-pharmaceutical-sales-revenue/ (last visited May 11, 2024)
Sales revenue of Kwang Dong Pharmaceutical Co., Ltd. from 2013 to 2023 (in billion South Korean won) [Graph], DART, March 22, 2024. [Online]. Available: https://www.statista.com/statistics/1269691/kwang-dong-pharmaceutical-sales-revenue/